News | Artificial Intelligence | September 07, 2023

Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology.

Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology.

Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology. Image courtesy: Paige


September 7, 2023 — Paige, a provider of end-to-end digital pathology solutions and clinical AI, has announced a collaboration with Microsoft to build what they refer to as the world’s largest image-based AI models for digital pathology and oncology. Paige developed the first Large Foundation Model using over one billion images from half a million pathology slides across multiple cancer types, according to a September 7 statement issued by the company. It further reports that Paige is developing a new AI model with Microsoft that is “orders-of-magnitude larger than any other image-based AI model existing today, configured with billions of parameters.”

The model assists in capturing the subtle complexities of cancer and serves as the cornerstone for the next generation of clinical applications and computational biomarkers that push the boundaries of oncology and pathology, noted the announcement. It allows the two companies to join forces in the fight against cancer, as it allows them to make headway in their collaboration to transform cancer diagnosis and patient care.

Paige Founder and Chief Scientist, Thomas Fuchs, Dr.Sc., said this of the collaboration: “Paige technology already goes beyond what is humanly possible today and helps physicians deliver better cancer care with AI support. By realizing the potential of generative AI at unprecedented scale, the Paige model collaboration with Microsoft is a milestone in the history of oncology.”

“By combining Microsoft’s world-class research and cloud infrastructure with Paige’s deep expertise and large-scale data, we are creating new AI models that will enable unprecedented insights into the pathology of cancer,” said Desney Tan, Vice President and Managing Director, Microsoft Health Futures. “Unleashing the power of AI is a game changer in advancing healthcare to improve lives,” Tan added.

In this next phase of development, Paige is incorporating up to four million digitized microscopy slides across multiple types of cancer from its unmatched petabyte-scale archive of clinical data. Paige will utilize Microsoft’s advanced supercomputing infrastructure to train the technology at scale and ultimately deploy it to hospitals and laboratories across the globe using Azure.

“Paige has been at the forefront of innovation since its inception, and by combining Microsoft’s expertise and enormous compute power with Paige’s deep expertise in AI, technology, and digital pathology, we strongly believe we will significantly advance the state-of-the-art in cancer imaging,” said Razik Yousfi, Paige SVP of Technology.  He added, “Through the development of this model, we will help improve the lives of the millions of people who are affected by cancer every day.”

Paige reports that it has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Notably, Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The statement also noted that the same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.

More information: www.paige.ai

Related coverage:

Paige and Ohio State Wexner Medical Center Collaborate to Study How AI Tools Can Bring Accuracy and Efficiency to Prostate Cancer Diagnosis in a Community Hospital Setting

Paige Applies the Power of AI to Improve Breast Cancer Diagnoses with the Launch of its Expanded Breast Suite

Paige Introduces Advanced Integration Capabilities to its AI Digital Pathology Platform


Related Content

News | Clinical Trials

May 30, 2024 — Researchers from Penn Medicine’s Abramson Cancer Center (ACC) and the Perelman School of Medicine at the ...

Time May 29, 2024
arrow
News | RSNA

May 29, 2024 — The Radiological Society of North America (RSNA) has launched the 2024 RSNA Lumbar Spine Degenerative ...

Time May 29, 2024
arrow
News | Breast Imaging

May 28, 2024 — iCAD, Inc., a global leader in clinically proven AI-powered cancer detection solutions, announced a ...

Time May 28, 2024
arrow
News | Radiology Education

May 24, 2024 — The American Society of Radiologic Technologists (ASRT) has announced that its ASRT Foundation has ...

Time May 24, 2024
arrow
News | Enterprise Imaging

May 24, 2024 — International medical imaging IT and cybersecurity company Sectra’s enterprise imaging solution has been ...

Time May 24, 2024
arrow
News | Artificial Intelligence

May 23, 2024 — NewVue.ai, born from the radiology technology pioneers behind peerVue and recognized as a trailblazer in ...

Time May 23, 2024
arrow
News | Radiation Therapy

May 23, 2024 — RaySearch Laboratories AB and C-RAD announced a collaboration agreement, aiming at jointly developing ...

Time May 23, 2024
arrow
News | FDA

May 22, 2024 — The U.S. Food and Drug Administration (FDA) has issued a recall of the Hologic Inc. BioZorb marker due to ...

Time May 22, 2024
arrow
News | Artificial Intelligence

May 22, 2024 — Lunit, a provider of Artificial intelligence (AI)-powered solutions for cancer diagnostics and ...

Time May 22, 2024
arrow
News | ASTRO

May 17, 2024 — Registration opens today for the American Society for Radiation Oncology's (ASTRO) 66th Annual Meeting ...

Time May 17, 2024
arrow
Subscribe Now